Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Maple Leaf Green World Inc. N.MGW

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Cannabis
"Maple Leaf Green World Inc and its subsidiaries focus on the cannabis industry in North America. It operates or funds three cannabis projects, in British Columbia, California, and Nevada. The company applies its eco-agriculture knowledge and cultivation technology to produce contaminant-free organic cannabis products."


NEO:MGW - Post by User

Maple Leaf Green World Inc. > Breaking PSAR
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by betsonvalueon Nov 14, 2018 12:36pm
57 Views
Post# 28973276

RE:RE:RE:RE:Breaking PSAR

RE:RE:RE:RE:Breaking PSAR
Grizzlyadams1 wrote: Better work on your value picks and your posts it’s not working out 


Lol, I'll be the judge of that. I was the one pointing out not to buy $0.22-0.19 because that was 'inflated'. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities